JSR Corporation and KBI Biopharma, Inc. Agree to Acquisition; INCJ and CMIC of Japan also participate
News • Mar 04, 2015 15:12 GMT
News • Jan 15, 2015 08:40 GMT
One of the hottest topics that came out the research for this year's BioProcess International Europe conference was single-use systems, and in particular, dual sourcing. ------------------------------------------
News • Jan 06, 2014 08:54 GMT
An mAb purification study tests a twin-column capture process
News • Dec 17, 2013 14:47 GMT
Comparing Protein A Resins for Monoclonal Antibody PurificationA prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.
News • Mar 13, 2013 08:13 GMT
Despite having lower expectations for the future, the biotechnology sector regards its current situation as better than last year.
News • Mar 08, 2013 11:56 GMT
Hear Marc's amazing story at next month's BioProcess International Europe conference ----- Reuse of syringes, all too common in under-funded clinics, kills 1.3 million each year. Marc Koska clues us in to this devastating global problem with facts, photos and hidden-camera footage. He shares his solution: a low-cost syringe that can't be used twice.
Scientific Publication of The Week - The intriguing options of multispecific antibody formats for treatment of cancer
News • Feb 08, 2013 10:37 GMT
The advent of various technologies for the generation of bi- and multispecific recombinant antibody-based molecules brought with it a multitude of formats for selecting target combinations. Some of the format options are outlined from a technical point of view.
News • Feb 07, 2013 15:24 GMT
GlaxoSmithKline ($GSK) aims to chop £1 billion ($1.57 billion) in annual spending in Europe, R&D and manufacturing by 2016 through technical improvements in research and manufacturing, but GSK CEO Andrew Witty expects job cuts to be part of the European cost savings.
Pfizer Will Evaluate Whether to Divide Drug Units, CEO Read Says Drew Armstrong - ©2013 Bloomberg News
News • Feb 05, 2013 09:00 GMT
Jan. 30 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, may consider dividing its branded medicines and generic products units into separate businesses, Chief Executive Officer Ian Read said.
News • Feb 04, 2013 17:23 GMT
ZURICH, Jan 24 (Reuters) - Swiss specialty chemicals and life sciences group Lonza reported a better than expected rise in profits on Thursday but dampened expectations of another big jump this year, taking the edge off a two-month rally in the share price.
News • Jan 31, 2013 08:00 GMT
Sartorius said today it finished last year with a 20% jump in profits, helped by growing U.S. revenue as well as growth in its bioprocessing, industrial weighing, and lab products and services units.
News • Jan 29, 2013 15:48 GMT
Sanofi (SAN) Chief Executive Officer Chris Viehbacher says investors are still underestimating the French company’s pipeline of experimental drugs.